Celldex Therapeutics, Inc. (NASDAQ:CLDX) on 18 December announced the appointment of Richard A. van den Broek to the Company’s Board of Directors. Mr. van den Broek currently serves as a Managing Partner of HSMR Advisors, LLC, an investment fund focused on the biotechnology industry. Celldex Therapeutics, Inc. (NASDAQ:CLDX) in last trading activity increased 0.39% to close at $18.25. Company weekly performance is 5.74% while its quarterly performance stands at 47.53%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is -45.24% away from its 52 week high.
InfuSystem Holdings Inc. (NYSEMKT:INFU) CEO Eric K. Steen bought 15,100 shares of InfuSystem Holdings stock on the open market in a transaction dated Tuesday, December 16th. The stock was purchased at an average cost of $2.73 per share, for a total transaction of $41,223.00. Following the acquisition, the chief executive officer now directly owns 109,953 shares of the company’s stock, valued at approximately $300,172. On last trading day InfuSystem Holdings, Inc. (NYSEMKT:INFU) moved up 5.00% to close at $3.15. Its volatility for the week is 6.34% while volatility for the month is 5.54%. INFU’s sales growth for past 5 years was 12.00% and its EPS growth for past 5 years was -31.50%. InfuSystem Holdings, Inc. (NYSEMKT:INFU) monthly performance is 18.42%.
Zoe’s Kitchen, Inc. (NYSE:ZOES) has 2.10% insider ownership while its institutional ownership stands at 20.40%. In last trading activity company’s stock closed at $29.91.
Horizon Pharma plc (NASDAQ:HZNP) on 28 December announced in a press release that the Company has filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Watson Laboratories Inc. (“WLF”) and certain of its affiliated companies, Actavis plc, and Actavis Inc., related to an Abbreviated New Drug Application (“ANDA”) that WLF filed with the US Food and Drug Administration (“FDA”) to market a generic version of PENNSAID® (diclofenac sodium topical solution) 2% w/w (“PENNSAID 2%”). On Wednesday shares of Horizon Pharma plc (NASDAQ:HZNP) closed at $12.89. Company’s EPS growth for next 5 years is recorded as 18.30%.
On 23 December VAALCO Energy, Inc. (NYSE:EGY) saw production resume from the Well 2-H in the Ebouri field, offshore Gabon, following successful wireline remedial work. The company said it expects production to stabilize at approximately 2,500 gross bpd, 700 net to VAALCO.On last trading day Vaalco Energy Inc. (NYSE:EGY) remains unchanged to close at $4.56. Its volatility for the week is 6.76% while volatility for the month is 8.98%. EGY’s EPS growth for past 5 years was 8.20%. Vaalco Energy Inc. (NYSE:EGY) monthly performance is -23.23%.